Skip to main content
Premium Trial:

Request an Annual Quote

Glaxo Buys Two More MassARRAYs From Sequenom

NEW YORK, Oct. 17 - Sequenom today said that GlaxoSmithKline likes its MassARRAY tools it bought earlier this year and has opened its wallet for two more units.


The sale also follows a collaboration between the two firms that helped Sequenom generate a "significant portion" of its SNP-assay portfolio, the company said.


Click here for more information.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more